trending Market Intelligence /marketintelligence/en/news-insights/trending/E0tjo7RWNmFqYDT4mHbp1Q2 content esgSubNav
In This List

BioPharmX receives non-compliance notice from NYSE

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


BioPharmX receives non-compliance notice from NYSE

BioPharmX Corp. received a non-compliance notice from the NYSE American LLC on Dec. 1 because its common stock was selling for a low price per share for a substantial period of time.

The company has until June 1, 2018 to effect a reverse stock split or show a sustained price improvement to remain listed on the exchange.

The notice doesn't have an immediate effect on BioPharmX's shares and they will continue trading until the given period.